Insomnia in adults

Opinion statement•Insomnia is a prevalent condition, existing as both a symptom and a syndrome, and is associated with significant impairments of daytime functioning, reduced quality of life, and increased risk of depression.•When insomnia is secondary to a psychiatric, medical, or another sleep disorder, treatment should focus initially on the underlying condition.•For acute and situational insomnia, treatment should address the precipitating factors when possible, but in certain circumstances (eg, stressful events, travel, or jet lag), a hypnotic medication is necessary to alleviate sleep difficulties. Benzodiazepine-receptor agents are the treatment of choice among the pharmacologic options.•For chronic and primary insomnia, behavior treatment should represent the main intervention, with hypnotic medications serving as an adjunct.•Behavior and pharmacologic treatments can be effectively combined in order to take advantage of the faster results obtained from medication administration, and the longer-lasting benefits associated with behavior interventions.•For recurrent insomnia, the use of intermittent medication can be very useful to prevent or minimize continued sleep difficulties.

[1]  W. Mendelson,et al.  A critical evaluation of the hypnotic efficacy of melatonin. , 1997, Sleep.

[2]  P. Hauri,et al.  Evaluation of chronic insomnia , 2000 .

[3]  Daniel J. Buysse,et al.  Nonpharmacologic Treatment of Chronic Insomnia , 1999, Sleep.

[4]  D J Foley,et al.  Sleep complaints among elderly persons: an epidemiologic study of three communities. , 1995, Sleep.

[5]  C. Morin,et al.  Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. , 1994, The American journal of psychiatry.

[6]  Short-Term Efficacy of Zaleplon in Older Patients with Chronic Insomnia , 2000 .

[7]  E. Simonsick,et al.  The Impact of Insomnia on Cognitive Functioning in Older Adults , 2001, Journal of the American Geriatrics Society.

[8]  E. Ernst,et al.  Valerian for insomnia: a systematic review of randomized clinical trials. , 2000, Sleep medicine.

[9]  P. Schweitzer,et al.  Ten-year trends in the pharmacological treatment of insomnia. , 1999, Sleep.

[10]  C. Morin,et al.  Cognitive behavior therapy to facilitate benzodiazepine discontinuation among hypnotic-dependent patients with insomnia * , 1995 .

[11]  Marie T. Farrell,et al.  Insomnia: assessment and management in primary care. , 1999, Sleep.

[12]  Charles M. Morin,et al.  Insomnia: Psychological Assessment and Management , 1993 .

[13]  J. Yesavage,et al.  A preliminary study comparing sleep restriction and relaxation treatments for insomnia in older adults. , 1991, Journal of gerontology.

[14]  A. Coenen,et al.  Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial. , 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

[15]  A. Holbrook,et al.  Meta-analysis of benzodiazepine use in the treatment of insomnia. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[16]  C. Morin,et al.  Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. , 1999, JAMA.

[17]  J. Hedner,et al.  Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia , 2000, International journal of geriatric psychiatry.

[18]  M. Thorpy,et al.  Treatment of chronic insomnia by restriction of time in bed. , 1987, Sleep.

[19]  P. Attali,et al.  Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia. , 1993, Clinical therapeutics.

[20]  Stefano Freguia Trichlorethylene Anaesthesia , 1953 .

[21]  P. Sugarman Psychotropic Drug Handbook , 1988 .

[22]  V. Wooten,et al.  Efficacy of behavioral versus triazolam treatment in persistent sleep-onset insomnia. , 1991, The American journal of psychiatry.

[23]  W. Hening,et al.  Beyond Benzodiazepines: Alternative Pharmacologic Agents for the Treatment of Insomnia , 1998, The Annals of pharmacotherapy.

[24]  G. Simon,et al.  Prevalence, burden, and treatment of insomnia in primary care. , 1997, The American journal of psychiatry.

[25]  Daniel J Buysse,et al.  Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. , 1997, JAMA.

[26]  Daniel J Buysse,et al.  Clinical diagnoses in 216 insomnia patients using the International Classification of Sleep Disorders (ICSD), DSM-IV and ICD-10 categories: a report from the APA/NIMH DSM-IV Field Trial. , 1994, Sleep.

[27]  Daniel J Buysse,et al.  Treating insomnia in older adults: taking a long-term view. , 1999, JAMA.

[28]  A. Coenen,et al.  Melatonin for Chronic Sleep Onset Insomnia in Children: A Randomized Placebo-Controlled Trial , 2001, Journal of child neurology.

[29]  P. Hauri Can we mix behavioral therapy with hypnotics when treating insomniacs? , 1997, Sleep.

[30]  W. Schaffner,et al.  Psychotropic drug use and the risk of hip fracture , 1987 .

[31]  D. Ford,et al.  Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? , 1989, JAMA.

[32]  Howard Gf rd Evaluation of insomnia. , 1986 .

[33]  J. Hoehns,et al.  Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia. , 1993, Clinical pharmacy.

[34]  C. Espie,et al.  A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. , 1989, Behaviour research and therapy.

[35]  S. Verlag Melatonin in elderly patients with insomnia A systematic review , 2001 .

[36]  J. Hetta,et al.  Age and the prevalence of insomnia in adult-hood , 1989 .

[37]  G. Sorock,et al.  Benzodiazepine sedatives and the risk of falling in a community-dwelling elderly cohort. , 1988, Archives of internal medicine.

[38]  D. Kupfer,et al.  Management of insomnia. , 1997, The New England journal of medicine.

[39]  C. Soldatos,et al.  Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies. , 1999, International clinical psychopharmacology.

[40]  K. Rickels,et al.  Diphenhydramine in Insomniac Family Practice Patients: A Double‐Blind Study , 1983, Journal of clinical pharmacology.

[41]  K. Greenwood,et al.  Identifying effective psychological treatments for insomnia: a meta-analysis. , 1995, Journal of consulting and clinical psychology.

[42]  E. Uhlenhuth,et al.  Insomnia and its treatment. Prevalence and correlates. , 1985, Archives of general psychiatry.

[43]  R. Grad Benzodiazepines for insomnia in community-dwelling elderly: a review of benefit and risk. , 1995, The Journal of family practice.

[44]  J. Edinger,et al.  The significance and management of persistent primary insomnia: the past, present and future of behavioral insomnia therapies. , 1999, Sleep medicine reviews.

[45]  S. Ancoli-Israel,et al.  Zaleplon, A Novel Nonbenzodiazepine Hypnotic, Effectively Treats Insomnia in Elderly Patients Without Causing Rebound Effects. , 1999, Primary care companion to the Journal of clinical psychiatry.

[46]  A. Holbrook,et al.  The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.